Click Here to download Acrobat Reader.

   Observations on the CATIE Schizophrenia Study
How Should the Data Be Translated Into Clinical Practice?
A supplement to Clinical Psychiatry News and supported by Pfizer, Inc.
A panel of experts met in November 2005 in Washington, DC, to discuss the first published results of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia study. Participants included several principal study investigators as well as experts in the treatment and management of schizophrenia and bipolar illness. The content of this supplement is based in part on that discussion.
Full Text    PDF

   Abuse Potential of Sleeping Agents: Liability Varies Among Agents
A supplement to Clinical Psychiatry News.
This CLINICAL UPDATE is supported by Takeda Pharmaceuticals North America, Inc.
Full Text    PDF

    CLINICAL UPDATE: Selected Issues in Psychiatry
This CLINICAL UPDATE is supported by an educational grant from UCB Pharma, Inc., and is a supplement to Clinical Psychiatry News.
This supplement is based on a faculty interview and poster reviews.
Full Text    PDF